Cargando…

A Multi-institutional Analysis of Diffuse Large B-cell Lymphoma (DLBCL) Treated with Consolidative Radiotherapy and the Impact of Cell-of-origin on Outcomes

BACKGROUND: Patients with diffuse large B-cell lymphoma (DLBCL) with bulky disease and/or those who fail to achieve complete response benefit from the addition of radiotherapy (RT). We aim to review the outcome, as well as determine the impact of cell-of-origin, on patients undergoing consolidative...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rajasooriyar, Chrishanthi, Tey, Jeremy, Wong, Lea Choung, Poon, Michelle, Nandini, Rao, Tham, Ivan, Vellayappan, Balamurugan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Sciendo 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6884940/ https://www.ncbi.nlm.nih.gov/pubmed/31652123 http://dx.doi.org/10.2478/raon-2019-0045

Ejemplares similares

The survival outcome and patterns of failure in node positive endometrial cancer patients treated with surgery and adjuvant radiotherapy with curative intent
por: Rajasooriyar, Chrishanthi, et al.
Publicado: (2014)

Palliative radiotherapy for gastric cancer: a systematic review and meta-analysis
por: Tey, Jeremy, et al.
Publicado: (2017)

Significance of bulky mass and residual tumor—Treated with or without consolidative radiotherapy—To the risk of relapse in DLBCL patients
por: Tokola, Susanna, et al.
Publicado: (2020)

Impact of epidermal growth factor receptor sensitizing mutations on outcomes of patients with non-small cell lung cancer treated with definitive thoracic radiation therapy: a systematic review and meta-analysis
por: Soon, Yu Yang, et al.
Publicado: (2017)

Breaking Bad News in Ethnic Settings: Perspectives of Patients and Families in Northern Sri Lanka
por: Rajasooriyar, Chrishanthi, et al.
Publicado: (2016)

Life-threatening Bleed Secondary to Tumor Shrinkage Effectively Palliated with Radiotherapy
por: Tseng, Michelle, et al.
Publicado: (2017)

Therapy Strategy of CD47 in Diffuse Large B-Cell Lymphoma (DLBCL)
por: Zhang, Wenqi, et al.
Publicado: (2021)

Diffuse Large B-Cell Lymphoma (DLBCL) in an Aged Raccoon (Procyon lotor)
por: D’Annunzio, Giulia, et al.
Publicado: (2022)

Impact of HIV infection on consolidative radiotherapy for non-Hodgkin diffuse large B-cell lymphoma
por: Medici, Carolina Trindade Mello, et al.
Publicado: (2020)

Outcomes of patients with spinal metastases from renal cell carcinoma treated with conventionally-fractionated external beam radiation therapy
por: Lee, Chia Ching, et al.
Publicado: (2020)

Retracted: Therapy Strategy of CD47 in Diffuse Large B-Cell Lymphoma (DLBCL)
por: Markers, Disease
Publicado: (2023)

Diffuse large B-cell lymphoma (DLBCL) with significant intravascular invasion. Close resemblance of its clinicopathological features to intravascular large B-cell lymphoma, but not to DLBCL-not otherwise specified
por: Itami, Hiroe, et al.
Publicado: (2021)

Adoption of prophylactic cranial irradiation (PCI) for extensive stage small cell lung cancer (ES-SCLC): a population based outcome study
por: Soon, Yu Yang, et al.
Publicado: (2018)

Racial differences in treatment and survival in older patients with diffuse large B-cell lymphoma (DLBCL)
por: Griffiths, Robert, et al.
Publicado: (2010)

Survivin expression in patients with newly diagnosed nodal diffuse large B cell lymphoma (DLBCL)
por: Markovic, O., et al.
Publicado: (2012)

Identification of a 14-Gene Prognostic Signature for Diffuse Large B Cell Lymphoma (DLBCL)
por: Feng, Pengcheng, et al.
Publicado: (2021)

Diffuse Large B-Cell Lymphoma (DLBCL): Early Patient Management and Emerging Treatment Options
por: Vodicka, Prokop, et al.
Publicado: (2022)

Stereotactic Body Radiotherapy for Oligometastatic Disease in Non-small Cell Lung Cancer
por: Wujanto, Caryn, et al.
Publicado: (2019)

Impact on survival through consolidation radiotherapy for diffuse large B-cell lymphoma: a comprehensive meta-analysis
por: Berger, Martin D., et al.
Publicado: (2020)

Quantifying the Changes in the Tumour Vascular Micro-environment in Spinal Metastases Treated with Stereotactic Body Radiotherapy - A Single Arm Prospective Study
por: Vellayappan, Balamurugan, et al.
Publicado: (2022)

The Immunology of DLBCL
por: Takahara, Taishi, et al.
Publicado: (2023)

Outcomes of Patients With Spinal Metastases From Prostate Cancer Treated With Conventionally-Fractionated External Beam Radiation Therapy
por: Lee, Chia Ching, et al.
Publicado: (2021)

Combined-modality hypofractionated radiotherapy for elderly patients with glioblastoma: setting a new standard
por: Vellayappan, Balamurugan A, et al.
Publicado: (2017)

Targeted Treatment of Adults with Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL): Tafasitamab in Context
por: Abdulhaq, Haifaa, et al.
Publicado: (2023)

CAR T-cell therapy for secondary CNS DLBCL
por: Ahmed, Gulrayz, et al.
Publicado: (2021)

Diffuse large B-cell lymphoma (DLBCL) is infiltrated with activated CD8(+) T-cells despite immune checkpoint signaling
por: Greenbaum, Adam M., et al.
Publicado: (2022)

Emerging radiotherapy technologies and trends in nasopharyngeal cancer
por: Tseng, Michelle, et al.
Publicado: (2020)

Check'-ing DLBCL
por: Salaverria, Itziar, et al.
Publicado: (2015)

DLBCL Coast to Coast
por: Tesio, Melania
Publicado: (2018)

GOALs in relapsed DLBCL
por: Rösler, Wiebke, et al.
Publicado: (2022)

SOCS1 Mutation Subtypes Predict Divergent Outcomes in Diffuse Large B-Cell Lymphoma (DLBCL) Patients
por: Schif, Birgit, et al.
Publicado: (2012)

The fear of lymphadenopathy: A cautionary case of sarcoidosis masquerading as recurrent diffuse large b-cell lymphoma (DLBCL)
por: Whooley, Peter D., et al.
Publicado: (2018)

Cost-Effectiveness of Molecularly Guided Treatment in Diffuse Large B-Cell Lymphoma (DLBCL) in Patients under 60
por: Regier, Dean A., et al.
Publicado: (2022)

P1268: DELINEATING THE NEOANTIGEN BURDEN AND TUMOUR MICROENVIRONMENT IN PATIENTS WITH DIFFUSE LARGE B CELL LYMPHOMA (DLBCL).
por: Jiang, Y., et al.
Publicado: (2022)

Post mastectomy radiotherapy for elderly patients with intermediate risk (T1-2N1 OR T3N0) breast cancer: a systematic review and meta-analysis
por: Tseng, Michelle, et al.
Publicado: (2020)

Hsp90 inhibition sensitizes DLBCL cells to cisplatin
por: Schmidt, Linnéa, et al.
Publicado: (2022)

Consolidative thoracic radiotherapy for extensive stage small cell lung cancer
por: Zhang, Xiaoli, et al.
Publicado: (2017)

The use of FDG-PET in diffuse large B cell lymphoma (DLBCL): predicting outcome following first line therapy
por: Coughlan, Monica, et al.
Publicado: (2014)

Extra- and Intracranial Diffuse Large B-Cell Lymphoma (DLBCL) Mimicking Meningioma: A Case Report and Literature Review
por: Matejka, Matthias, et al.
Publicado: (2023)

Comparison of four techniques for spine stereotactic body radiotherapy: Dosimetric and efficiency analysis
por: Aljabab, Saif, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_2k4f8up0884ikcjjcusmgjgbcj